Axillary Lymphadenopathy: Differential Diagnosis and Evaluation

Lymphadenopathy, characterized by the enlargement of lymph nodes, is a common clinical finding that can indicate a wide range of underlying conditions, from benign infections to serious malignancies. When lymphadenopathy occurs in the axillary region, it presents a unique diagnostic challenge due to the diverse etiologies associated with this specific anatomical location. This article delves into the differential diagnosis of axillary lymphadenopathy, providing a comprehensive overview for healthcare professionals.

Introduction to Axillary Lymphadenopathy

The lymphatic system is a critical component of the body’s immune defense, filtering substances and housing lymphocytes, which are key players in immune surveillance. Lymph nodes, strategically positioned throughout the body, serve as filtration stations. Axillary lymph nodes, located in the armpit, drain lymph from the upper limb, breast, chest wall, and upper back. Consequently, axillary lymphadenopathy, or swelling of these nodes, can be a sign of local or systemic disease processes. While lymphadenopathy in general is a broad topic, understanding the specific differential diagnosis for axillary lymphadenopathy is crucial for accurate diagnosis and appropriate management.

Etiology of Axillary Lymphadenopathy

Axillary lymphadenopathy is a non-specific sign with a broad spectrum of potential causes. These causes can be broadly categorized into infectious, malignant, autoimmune, and other less common etiologies.

Infectious Causes

Infections are a frequent cause of axillary lymphadenopathy. These can be bacterial, viral, fungal, or parasitic in origin.

• Bacterial Infections: Common bacterial infections leading to axillary lymphadenopathy include cellulitis, erysipelas, and abscesses of the upper limb. Cat-scratch disease, caused by Bartonella henselae, is a notable cause, often presenting with axillary lymphadenopathy following a scratch or bite from a cat. Tuberculosis can also manifest as axillary lymphadenitis, particularly in immunocompromised individuals or in regions with high TB prevalence.
• Viral Infections: Viral infections, both systemic and localized, can result in axillary lymphadenopathy. Common viral culprits include Epstein-Barr virus (EBV), cytomegalovirus (CMV), and human immunodeficiency virus (HIV). Localized viral infections, such as herpes zoster (shingles), can also cause lymph node enlargement in the axilla.
• Fungal and Parasitic Infections: While less common, fungal infections like sporotrichosis and parasitic infections such as toxoplasmosis can also present with axillary lymphadenopathy, especially in specific geographical locations or in immunocompromised patients.

Malignant Causes

Malignancy is a significant concern in the differential diagnosis of axillary lymphadenopathy. It can be primary or secondary, representing metastasis from distant sites.

• Breast Cancer: Axillary lymph node involvement is a critical factor in the staging and prognosis of breast cancer. Metastasis to axillary lymph nodes is common in breast cancer and can be the first sign of malignancy.
• Lymphoma: Both Hodgkin lymphoma and non-Hodgkin lymphoma can present with axillary lymphadenopathy. Lymphoma should be considered, especially in cases of persistent, painless lymph node enlargement.
• Leukemia: While less common than lymphoma, leukemia can also manifest with lymphadenopathy, including in the axillary region, as part of a more generalized lymphadenopathy.
• Metastatic Cancers: Metastasis from other cancers, such as melanoma, lung cancer, and head and neck cancers, can also involve axillary lymph nodes. The location of the primary malignancy will influence the likelihood of axillary involvement.

Autoimmune and Inflammatory Causes

Autoimmune and inflammatory conditions can also lead to axillary lymphadenopathy, often as part of a more generalized lymphadenopathy.

• Sarcoidosis: Sarcoidosis, a systemic granulomatous disease, can involve lymph nodes in various locations, including the axilla. Axillary lymphadenopathy in sarcoidosis is often bilateral and may be accompanied by hilar lymphadenopathy.
• Systemic Lupus Erythematosus (SLE): SLE, a chronic autoimmune disease, can cause generalized lymphadenopathy, including axillary involvement.
• Rheumatoid Arthritis (RA): RA, another systemic autoimmune disease, can also present with lymphadenopathy, although it is less common than in SLE.
• Dermatopathic Lymphadenopathy: This benign reactive lymphadenopathy occurs in response to chronic skin conditions such as eczema or psoriasis affecting the upper limb and can involve axillary nodes.

Other Causes

• Medications: Certain medications, such as phenytoin, hydralazine, and allopurinol, can cause drug-induced lymphadenopathy, although this is less common in the axillary region specifically unless the drug reaction is systemic.
• Silicone Implants: Silicone implant rupture can lead to silicone lymphadenopathy in axillary nodes, a foreign body reaction to silicone material. This is an important consideration in patients with breast implants presenting with axillary lymphadenopathy.
• Benign Reactive Hyperplasia: In many cases, especially in children and young adults, axillary lymphadenopathy can be due to benign reactive hyperplasia in response to minor, often unidentified, infections or inflammatory stimuli.

Differential Diagnosis of Axillary Lymphadenopathy

Developing a differential diagnosis for axillary lymphadenopathy requires careful consideration of patient history, physical examination findings, and appropriate investigations. Key factors in differentiating the causes include:

• Patient History:

  • Age: Benign causes are more common in children and young adults, while malignancy is more concerning in older individuals.
  • Duration and Progression: Acute onset suggests infection, while chronic, progressive lymphadenopathy raises suspicion for malignancy or chronic inflammatory conditions.
  • Associated Symptoms: Fever, night sweats, weight loss (B symptoms) suggest lymphoma or systemic infection. Local pain and tenderness are more typical of infection or inflammation. Breast changes, skin lesions, or systemic symptoms of autoimmune disease are important clues.
  • Risk Factors: History of cancer, silicone implants, recent infections or animal exposure, autoimmune conditions, medications, and travel history are relevant.

• Physical Examination:

  • Location and Distribution: Localized axillary lymphadenopathy is more likely due to regional infection or breast pathology. Generalized lymphadenopathy suggests systemic illness.
  • Size: Lymph nodes larger than 1 cm in the axilla are considered abnormal and warrant further investigation.
  • Consistency: Hard, fixed nodes are more concerning for malignancy, while soft, mobile, and tender nodes are more suggestive of benign conditions like infection or inflammation.
  • Associated Findings: Examination of the breast, skin of the upper limb and chest wall, and assessment for hepatosplenomegaly or other sites of lymphadenopathy is crucial.

Evaluation of Axillary Lymphadenopathy

The evaluation of axillary lymphadenopathy is guided by the clinical suspicion based on history and physical exam.

1. Initial Assessment: A thorough history and physical examination are paramount. Assess for risk factors, associated symptoms, and characteristics of the lymph nodes.

2. Laboratory Investigations:

   • Complete Blood Count (CBC) and Differential: To evaluate for signs of infection, leukemia, or systemic illness.
   • Inflammatory Markers: ESR and CRP may be elevated in infections and autoimmune conditions.
   • Specific Serologies: If infection is suspected, serological tests for EBV, CMV, HIV, Bartonella henselae, tuberculosis, or fungal infections may be indicated.
   • Lactate Dehydrogenase (LDH): Elevated LDH can be seen in lymphomas and other malignancies.

3. Imaging Studies:

   • Ultrasound: Axillary ultrasound is often the first-line imaging modality. It can assess lymph node size, shape, vascularity, and presence of cystic changes, helping to differentiate benign from suspicious nodes.
   • Mammography and Breast Ultrasound: In women, especially when breast pathology is suspected, mammography and breast ultrasound are essential to evaluate for breast cancer.
   • Computed Tomography (CT) Scan: CT of the chest, abdomen, and pelvis may be indicated to evaluate for generalized lymphadenopathy, underlying malignancy, or systemic disease, especially if initial investigations are inconclusive or malignancy is suspected.
   • Magnetic Resonance Imaging (MRI): MRI may be used in specific cases, such as evaluating breast cancer extent or soft tissue masses.
   • Positron Emission Tomography-Computed Tomography (PET-CT): PET-CT is useful in staging lymphoma and other malignancies and can help identify metabolically active lymph nodes.

4. Lymph Node Biopsy: If the etiology of axillary lymphadenopathy remains unclear after initial evaluation and imaging, or if malignancy is suspected, a lymph node biopsy is indicated.

   • Fine Needle Aspiration (FNA): FNA can be performed under ultrasound guidance and is useful for initial cytological evaluation. However, it may not always provide sufficient tissue for definitive diagnosis, especially for lymphoma.
   • Core Needle Biopsy: Core needle biopsy, also guided by ultrasound, provides a larger tissue sample than FNA and is often preferred for initial tissue diagnosis.
   • Excisional Biopsy: Excisional biopsy, the surgical removal of an entire lymph node, is the gold standard for diagnosing lymphadenopathy, particularly when lymphoma is suspected or when less invasive biopsies are inconclusive.

Alt text: Chest X-ray showing bilateral hilar lymphadenopathy, which can be related to systemic conditions also causing axillary lymph node swelling.

Treatment and Management

Treatment of axillary lymphadenopathy is directed at the underlying cause.

• Infections: Antibiotics, antivirals, antifungals, or antiparasitic medications are used depending on the specific infectious agent.
• Malignancies: Treatment for malignant axillary lymphadenopathy depends on the type and stage of cancer. It may involve surgery, radiation therapy, chemotherapy, targeted therapy, or immunotherapy.
• Autoimmune and Inflammatory Conditions: Management involves treating the underlying autoimmune or inflammatory disease, often with immunosuppressive medications or corticosteroids.
• Drug-Induced Lymphadenopathy: Discontinuation of the offending medication is usually sufficient.
• Benign Reactive Hyperplasia: Often resolves spontaneously without specific treatment.

Prognosis

The prognosis of axillary lymphadenopathy varies widely depending on the underlying cause. Benign causes usually have an excellent prognosis with appropriate treatment or spontaneous resolution. Malignant causes have a more guarded prognosis, which depends on the type and stage of cancer, as well as the response to treatment. Early diagnosis and appropriate management are crucial for optimizing outcomes.

Conclusion

Axillary lymphadenopathy presents a complex diagnostic challenge due to its diverse etiology. A systematic approach involving detailed history taking, thorough physical examination, and judicious use of laboratory and imaging investigations, including biopsy when indicated, is essential for accurate differential diagnosis. Understanding the broad spectrum of potential causes, from infections to malignancies and autoimmune disorders, allows clinicians to effectively evaluate and manage patients presenting with axillary lymphadenopathy, ensuring timely and appropriate intervention.

References

1. Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A. Peripheral lymphadenopathy: approach and diagnostic tools. Iran J Med Sci. 2014 Mar;39(2 Suppl):158-70. [PMC free article: PMC3993046] [PubMed: 24753638]
2. Ferrer R. Lymphadenopathy: differential diagnosis and evaluation. Am Fam Physician. 1998 Oct 15;58(6):1313-20. [PubMed: 9803196]
3. Knight PJ, Mulne AF, Vassy LE. When is lymph node biopsy indicated in children with enlarged peripheral nodes? Pediatrics. 1982 Apr;69(4):391-6. [PubMed: 7070884]
4. Williamson HA. Lymphadenopathy in a family practice: a descriptive study of 249 cases. J Fam Pract. 1985 May;20(5):449-52. [PubMed: 3989485]
5. Gowing NF. Tumours of the lymphoreticular system: nomenclature, histogenesis, and behaviour. J Clin Pathol Suppl (R Coll Pathol). 1974;7:103-7. [PMC free article: PMC1347234] [PubMed: 4598345]
6. Mesin L, Ersching J, Victora GD. Germinal Center B Cell Dynamics. Immunity. 2016 Sep 20;45(3):471-482. [PMC free article: PMC5123673] [PubMed: 27653600]
7. Kumar BV, Connors TJ, Farber DL. Human T Cell Development, Localization, and Function throughout Life. Immunity. 2018 Feb 20;48(2):202-213. [PMC free article: PMC5826622] [PubMed: 29466753]
8. Strickler JG, Warnke RA, Weiss LM. Necrosis in lymph nodes. Pathol Annu. 1987;22 Pt 2:253-82. [PubMed: 3317224]
9. Fend F, Cabecadas J, Gaulard P, Jaffe ES, Kluin P, Kuzu I, Peterson L, Wotherspoon A, Sundström C. Early lesions in lymphoid neoplasia: Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology, in Uppsala, Sweden. J Hematop. 2012 Sep;5(3) [PMC free article: PMC3845020] [PubMed: 24307917]
10. Elmore SA. Histopathology of the lymph nodes. Toxicol Pathol. 2006;34(5):425-54. [PMC free article: PMC1892634] [PubMed: 17067938]
11. Lucia HL, Griffith BP, Hsiung GD. Lymphadenopathy during cytomegalovirus-induced mononucleosis in guinea pigs. Arch Pathol Lab Med. 1985 Nov;109(11):1019-23. [PubMed: 2996461]
12. Eberle FC, Mani H, Jaffe ES. Histopathology of Hodgkin’s lymphoma. Cancer J. 2009 Mar-Apr;15(2):129-37. [PubMed: 19390308]
13. Johns ME, Moscinski LC, Sokol L. Phenytoin-associated lymphoadenopathy mimicking a peripheral T-cell lymphoma. Mediterr J Hematol Infect Dis. 2010 Sep 07;2(2):e2010028. [PMC free article: PMC3033141] [PubMed: 21415974]
14. Sumi M, Ohki M, Nakamura T. Comparison of sonography and CT for differentiating benign from malignant cervical lymph nodes in patients with squamous cell carcinoma of the head and neck. AJR Am J Roentgenol. 2001 Apr;176(4):1019-24. [PubMed: 11264102]
15. Weiss LM, O’Malley D. Benign lymphadenopathies. Mod Pathol. 2013 Jan;26 Suppl 1:S88-96. [PubMed: 23281438]
16. Gaddey HL, Riegel AM. Unexplained Lymphadenopathy: Evaluation and Differential Diagnosis. Am Fam Physician. 2016 Dec 01;94(11):896-903. [PubMed: 27929264]
17. Armitage JO. Staging non-Hodgkin lymphoma. CA Cancer J Clin. 2005 Nov-Dec;55(6):368-76. [PubMed: 16282281]
18. Chau I, Kelleher MT, Cunningham D, Norman AR, Wotherspoon A, Trott P, Rhys-Evans P, Querci Della Rovere G, Brown G, Allen M, Waters JS, Haque S, Murray T, Bishop L. Rapid access multidisciplinary lymph node diagnostic clinic: analysis of 550 patients. Br J Cancer. 2003 Feb 10;88(3):354-61. [PMC free article: PMC2747551] [PubMed: 12569376]